Zobrazeno 1 - 8
of 8
pro vyhledávání: '"BV Regimen"'
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 2, Pp 657-665 (2019)
Case Reports in Oncology, Vol 12, Iss 2, Pp 657-665 (2019)
Fluorouracil plus oxaliplatin (L-OHP) (FOLFOX) plus bevacizumab (BV) therapy is commonly administered to patients with metastatic colorectal cancer. However, few reports have described L-OHP therapy in hemodialysis patients, and the efficacy and safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d26d6f5f2cf4c7806695496edcfa10
http://europepmc.org/articles/PMC6751430
http://europepmc.org/articles/PMC6751430
Publikováno v:
Acta haematologica. 143(2)
Background: In multiple myeloma (MM), relapse is a frequent complication after autologous hematopoietic stem cell transplant (ASCT). To reduce the risk of relapse, additional therapy has been added post-ASCT. In a nontransplant relapse setting, the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac08abb724512446069b686b32dfd58
https://pubmed.ncbi.nlm.nih.gov/31434076
https://pubmed.ncbi.nlm.nih.gov/31434076
Autor:
Evert M. Noordijk, J.M.M. Raemaekers, Johanna Kluin-Nelemans, Elizabeth C. Moser, M. van Glabbeke, I. Teodorovic, C De Wolf-Peeters, Patrice Carde, Umberto Tirelli, Joke W. Baars
Publikováno v:
European Journal of Cancer, 40, 4, pp. 474-80
European Journal of Cancer, 40, 474-80
European Journal of Cancer, 40(4), 474-480. ELSEVIER SCI LTD
European Journal of Cancer, 40, 474-80
European Journal of Cancer, 40(4), 474-480. ELSEVIER SCI LTD
Item does not contain fulltext We analysed data from 936 newly-diagnosed patients with advanced, aggressive non-Hodgkin's lymphoma (NHL) treated in three randomised European Organisation for Research and Treatment of Cancer (EORTC) trials performed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2225eb19ffd16598359479f6fadbe6d
https://doi.org/10.1016/j.ejca.2003.11.003
https://doi.org/10.1016/j.ejca.2003.11.003
Publikováno v:
Drug Safety. 20:403-425
Kaposi's sarcoma is the most common malignancy observed in patients with HIV-1 infection, and causes considerable morbidity and, when the lungs are involved, mortality. Therapy should be based on an evaluation of prognostic factors, in particular the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28806e38f62212ac5414a8c5df0c4a76
https://doi.org/10.2165/00002018-199920050-00002
https://doi.org/10.2165/00002018-199920050-00002
Autor:
M. Gil Gil, Á. Rodríguez Sánchez, J.M. Vieitez, Saulo A. Vázquez, José L. Andrade, Francisco M González V, L.M. Rodríguez, Elena Pujol, Joaquín M. Sepúlveda, Oscar Gallego
Publikováno v:
Annals of Oncology. 25:iv140
Aim: To date, sociodemographic data and therapeutic management have not been well explored in GBM patients (p) at Spanish level. The GEINO-10 study was designed to evaluate the clinical profile and therapeutic behaviors in p with intra-axial brain tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::503a6d5f29495570d953356195010f40
https://doi.org/10.1093/annonc/mdu330.11
https://doi.org/10.1093/annonc/mdu330.11
Autor:
Satoshi Morita, Ayumu Goto, Nakajima Takako, Yasuo Hamamoto, Tomohiro Nishina, Kentaro Yamazaki, Yasuhide Yamada, Norisuke Nakayama, Takashi Ura, Ken Shimada, Tatsuro Yamaguchi, Junichi Sakamoto
Publikováno v:
Annals of Oncology. 23:iv99
Introduction In Japan, capecitabine is mainly used in combination with oxaliplatin (XELOX) in treatment for metastatic colorectal cancer (mCRC) since its approval in 2010. The results of capecitabine plus Irinotecan (CPT) (XELIRI) with or without bev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37342356f028a28318004a6a0efc8d5e
https://doi.org/10.1016/s0923-7534(20)30172-1
https://doi.org/10.1016/s0923-7534(20)30172-1
Autor:
Jane Salodof Macneil
Publikováno v:
Family Practice News. 35:43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30624e196d258c5e6dcc5dbea6404829
https://doi.org/10.1016/s0300-7073(05)71229-9
https://doi.org/10.1016/s0300-7073(05)71229-9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.